Arcutis Biotherapeutics (ARQT) had the highest return between January 23, 2024 and January 30, 2024 by a mid-cap US stock, returning 63.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Arcutis Biotherapeutics (ARQT) | 1/23/2024 - 1/30/2024 | 63.51% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 1/23/2024 - 1/30/2024 | 37.52% |
Terawulf (WULF) | 1/23/2024 - 1/30/2024 | 37.23% |
Advantage Solutions (ADVWW) | 1/23/2024 - 1/30/2024 | 35.42% |
American Superconductor (AMSC) | 1/23/2024 - 1/30/2024 | 32.15% |
Nuscale Power (SMR) | 1/23/2024 - 1/30/2024 | 31.39% |
CG Oncology, Inc Common stock (CGON) | 1/23/2024 - 1/30/2024 | 25.86% |
Sanmina (SANM) | 1/23/2024 - 1/30/2024 | 23.97% |
Purecycle Technologies (PCT) | 1/23/2024 - 1/30/2024 | 23.58% |
Power Solutions International, Inc Common Stock (PSIX) | 1/23/2024 - 1/30/2024 | 23.56% |
Coca-Cola Consolidated (COKE) | 1/23/2024 - 1/30/2024 | 23.25% |
CleanSpark (CLSK) | 1/23/2024 - 1/30/2024 | 23.1% |
American Bitcoin (ABTC) | 1/23/2024 - 1/30/2024 | 22.87% |
Skeena Resources (SKE) | 1/23/2024 - 1/30/2024 | 20% |
Helmerich and Payne (HP) | 1/23/2024 - 1/30/2024 | 20% |
Hut 8 Corp Common Stock (HUT) | 1/23/2024 - 1/30/2024 | 19.39% |
PBF Energy (PBF) | 1/23/2024 - 1/30/2024 | 19.09% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 1/23/2024 - 1/30/2024 | 18.45% |
Grupo Financiero Galicia SA ADR (GGAL) | 1/23/2024 - 1/30/2024 | 17.46% |
Ocular Therapeutix (OCUL) | 1/23/2024 - 1/30/2024 | 17.42% |
Bread Financial (BFH) | 1/23/2024 - 1/30/2024 | 16.82% |
Lucid (LCID) | 1/23/2024 - 1/30/2024 | 16.11% |
Dave (DAVE) | 1/23/2024 - 1/30/2024 | 15.46% |
Grifols SA ADR (GRFS) | 1/23/2024 - 1/30/2024 | 15.22% |
Oscar Health (OSCR) | 1/23/2024 - 1/30/2024 | 14.78% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
